Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Preferred Stock	Common Stock	Capital Surplus	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss), net	Treasury Stock
Balance Beginning at Dec. 31, 2022	$ 1,978,967	$ 39	$ 151,819	$ 2,260,290	$ (403,931)	$ 2,448	$ (31,698)
Net Income (Loss)	(18,867)				(18,867)
Stock-based compensation expense	2,688			2,688
Incentive compensation units distributed	(2,036)		359	(359)			(2,036)
Common stock and Series B Preferred Stock dividends declared	(7,808)				(7,808)
Common stock issued for 401(k) match	2,256		93	2,163
Common stock issued under ATM Program	25,888		1,063	24,825
Other comprehensive income (loss)	11,748					11,748
Balance Ending at Jun. 30, 2023	1,992,836	39	153,334	2,289,607	(430,606)	14,196	(33,734)
Balance Beginning at Mar. 31, 2023	1,992,157	39	152,536	2,273,793	(410,995)	8,964	(32,180)
Net Income (Loss)	(15,694)				(15,694)
Stock-based compensation expense	1,498			1,498
Common stock and Series B Preferred Stock dividends declared	(3,917)				(3,917)
Common stock issued for 401(k) match	1,111		43	1,068
Common stock issued under ATM Program	14,003		521	13,482
Common stock issued as incentive compensation	(1,554)		234	(234)			(1,554)
Other comprehensive income (loss)	5,232					5,232
Balance Ending at Jun. 30, 2023	1,992,836	39	153,334	2,289,607	(430,606)	14,196	(33,734)
Balance Beginning at Dec. 31, 2023	1,968,104	39	156,076	2,343,747	(503,861)	5,837	(33,734)
Net Income (Loss)	22,117				22,117
Stock-based compensation expense	3,321			3,321
Incentive compensation units distributed	2,158		445	2,910			(1,197)
Common stock issued as compensation to interim CEO (10,831 shares)	55		3	52
Common stock and Series B Preferred Stock dividends declared	(7,994)				(7,994)
Common stock issued for 401(k) match	2,322		122	2,200
Common stock issued to directors (145,687 shares)	770		37	733
Common stock issued under ATM Program	1,103		62	1,041
Other comprehensive income (loss)	(11,891)					(11,891)
Balance Ending at Jun. 30, 2024	1,980,065	39	156,745	2,354,004	(489,738)	(6,054)	(34,931)
Balance Beginning at Mar. 31, 2024	1,958,630	39	156,447	2,350,249	(513,608)	434	(34,931)
Net Income (Loss)	27,870				27,870
Stock-based compensation expense	2,157			2,157
Incentive compensation units distributed			205	(205)
Common stock issued as compensation to interim CEO (10,831 shares)	55		3	52
Common stock and Series B Preferred Stock dividends declared	(4,000)				(4,000)
Common stock issued for 401(k) match	1,071		53	1,018
Common stock issued to directors (145,687 shares)	770		37	733
Other comprehensive income (loss)	(6,488)					(6,488)
Balance Ending at Jun. 30, 2024	$ 1,980,065	$ 39	$ 156,745	$ 2,354,004	$ (489,738)	$ (6,054)	$ (34,931)